Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
Background and aims No drugs are currently approved for Coronavirus Disease-2019 (COVID-19), although some have been tried. In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and COV...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12264
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S1871402120300515?via%3Dihub
http://hdl.handle.net/20.500.12010/12264
https://doi.org/10.1016/j.dsx.2020.03.011
- Palabra clave:
- Diabetes
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Chloroquine
Hydroxychloroquine
- Rights
- License
- Acceso restringido